We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New X-Ray Source for Molecular Imaging

By Biotechdaily staff writers
Posted on 07 Jul 2005
Scientists are evaluating what they call the "Ferrari” of synchotron beamline-high technology research facilities for imaging molecules.

At the Argonne National Laboratory (Argonne, IL, USA), several innovative design characteristics that allow for automation, additional research stations, and more refined information will enable scientists to study molecules in greater detail and convert these data into new therapeutic medications, eventually benefiting research and human health. More...
The project is supported by the U.S National Institutes of Health (NIH) in collaboration with Argonne National Laboratory, part of the U.S. Department of Energy (DOE).

Synchrotrons produce powerful x-ray beams that scientists utilize use to image the three-dimensional (3D) shapes of molecules. However, only a small amount of these large-scale facilities exist worldwide. Biochemists, biologists, and other scientists apply for access to approximately 45 experimental stations in the United States. Many want time to use the advanced photon source (APS), a DOE-user facility at Argonne offering the most powerful x-ray beams in the Western Hemisphere.

The additional experimental stations at APS can accommodate many robotic and automated tools. This ability could enable scientists to conduct their studies from their home laboratories. The beamlines are the first to also utilize the innovative APS technology that splits one x-ray beam into two and then adjusts each one so it is exactly as strong as the original. "The ability to do two experiments simultaneously from the same light source is a big bonus,” explained Dr. Smith. "It doubles the value of real estate at the synchrotron.”

But where the new beamlines really demonstrate their strength is in their capacity to generate very fine x-ray beams. This characteristic enables scientists to retrieve data on molecules that have been difficult to work with in the past. The new facilities have already produced exciting results. One research group has succeeded in producing a detailed structure of the bacteria-infecting HK97 virus--a significant achievement given that most viruses are complicated and difficult to image at high resolutions. Knowing the structures of viruses and proteins and how they bind to other molecules will help investigators develop drugs that block those interactions.

Structural biologists will have general access to one of the beamlines later in 2005. The team expects all three to be fully operational by summer of 2007.




Related Links:
Argonne National Laboratory

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Urine Analyzer
respons® UDS100
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.